| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.042 | 0.4 |